The Food and Drug administration has cleared GE Healthcare's AdvantageALA, lung analysis software technology for CT used to evaluate lung nodules and other lesions.
Waukesha, WI-based GE said AdvantageALA also features a new digital contrast agent that will automatically highlight suspicious anatomical regions such as lung nodules.
By AuntMinnie.com staff writers
November 30, 2004
Related Reading
GE's RSNA advances include 64-slice PET/CT, HDMR, November 28, 2004
GE, Maquet in MR-guided surgery collaboration, November 24, 2004
GE notches Hawkeye mark, November 24, 2004
Road to RSNA, GE Healthcare, November 10, 2004
Copyright © 2004 AuntMinnie.com